-
1
-
-
45549083447
-
Therapeutic uses of botulinum toxin: From facial palsy to autonomic disorders
-
18476790 10.1517/14712598.8.6.791
-
De Maio M (2008) Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders. Expert Opin Biol Ther 8:791-798
-
(2008)
Expert Opin Biol Ther
, vol.8
, pp. 791-798
-
-
De Maio, M.1
-
2
-
-
77954705991
-
International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments - Introduction
-
20633176 10.1111/j.1468-1331.2010.03125.x
-
Esquenazi A, Novak I, Sheean G, Singer BJ, Ward AB (2010) International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments - introduction. Eur J Neurol 17(Suppl 2):1-8
-
(2010)
Eur J Neurol
, vol.17
, Issue.SUPPL. 2
, pp. 1-8
-
-
Esquenazi, A.1
Novak, I.2
Sheean, G.3
Singer, B.J.4
Ward, A.B.5
-
3
-
-
79955902288
-
Botulinum toxin type A: Exploring new indications
-
10.1358/dot.2010.46.9.1524356 1:CAS:528:DC%2BC3MXht1Wms7vL
-
Brashear A (2010) Botulinum toxin type A: exploring new indications. Drugs Today (Barc) 46:671-682
-
(2010)
Drugs Today (Barc)
, vol.46
, pp. 671-682
-
-
Brashear, A.1
-
4
-
-
67650433813
-
Dose equivalence of two commercial preparations of botulinum neurotoxin type A: Time for a reassessment?
-
19463043 10.1185/03007990903028203 1:CAS:528:DC%2BD1MXnsFKqsbs%3D
-
Wohlfarth K, Sycha T, Ranoux D, Naver H, Caird D (2009) Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment? Curr Med Res Opin 25:1573-1584
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 1573-1584
-
-
Wohlfarth, K.1
Sycha, T.2
Ranoux, D.3
Naver, H.4
Caird, D.5
-
5
-
-
79958861460
-
® (incobotulinumtoxinA) for the treatment of blepharospasm
-
21691580 1:CAS:528:DC%2BC3MXns1Sjtbk%3D
-
® (incobotulinumtoxinA) for the treatment of blepharospasm. Clin Ophthalmol 5:725-732
-
(2011)
Clin Ophthalmol
, vol.5
, pp. 725-732
-
-
Park, J.1
Lee, M.S.2
Harrison, A.R.3
-
6
-
-
84880917543
-
Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
-
21966203 10.2147/OPTH.S24394 1:CAS:528:DC%2BC3MXhtlamurnO
-
Pickett A (2011) Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data. Clin Ophthalmol 5:1287-1290
-
(2011)
Clin Ophthalmol
, vol.5
, pp. 1287-1290
-
-
Pickett, A.1
-
7
-
-
34047207959
-
Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia
-
17385940 10.2165/00003495-200767050-00003 1:CAS:528:DC%2BD2sXlsVCmtbw%3D
-
Jost WH, Blümel J, Grafe S (2007) Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia. Drugs 67:669-683
-
(2007)
Drugs
, vol.67
, pp. 669-683
-
-
Jost, W.H.1
Blümel, J.2
Grafe, S.3
-
8
-
-
36549049448
-
Pharmacology of therapeutic botulinum toxin preparations
-
18033601 10.1080/09638280701568296
-
Dressler D, Benecke R (2007) Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 29:1761-1768
-
(2007)
Disabil Rehabil
, vol.29
, pp. 1761-1768
-
-
Dressler, D.1
Benecke, R.2
-
9
-
-
77953344039
-
Botulinum toxin for treatment of dystonia
-
20590814 10.1111/j.1468-1331.2010.03058.x
-
Dressler D (2010) Botulinum toxin for treatment of dystonia. Eur J Neurol 17(Suppl 1):88-96
-
(2010)
Eur J Neurol
, vol.17
, Issue.SUPPL. 1
, pp. 88-96
-
-
Dressler, D.1
-
10
-
-
0027998242
-
Potency equivalence of botulinum toxin preparations
-
7837204 1:STN:280:DyaK2M7jvV2qtQ%3D%3D
-
Hambleton P, Pickett AM (1994) Potency equivalence of botulinum toxin preparations. J R Soc Med 87:719
-
(1994)
J R Soc Med
, vol.87
, pp. 719
-
-
Hambleton, P.1
Pickett, A.M.2
-
11
-
-
33947601155
-
The protein load of therapeutic botulinum toxins
-
17388970 10.1111/j.1468-1331.2007.01683.x 1:STN:280: DC%2BD2s7osl2isA%3D%3D
-
Pickett A, O'Keeffe R, Panjwani N (2007) The protein load of therapeutic botulinum toxins. Eur J Neurol 14:e11
-
(2007)
Eur J Neurol
, vol.14
, pp. 11
-
-
Pickett, A.1
O'Keeffe, R.2
Panjwani, N.3
-
12
-
-
67349097370
-
®) in volunteers: A double-blind, randomized, dose-ranging study
-
18854916 10.1007/s00415-008-0031-7 1:CAS:528:DC%2BD1MXislSqsr0%3D
-
®) in volunteers: a double-blind, randomized, dose-ranging study. J Neurol 255:1932-1939
-
(2008)
J Neurol
, vol.255
, pp. 1932-1939
-
-
Wohlfarth, K.1
Schwandt, I.2
Wegner, F.3
-
13
-
-
34147222256
-
Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins
-
17414940 10.1097/01.WNF.0000240951.18821.50 1:CAS:528: DC%2BD2sXjvVKhsrk%3D
-
Wohlfarth K, Muller C, Sassin I et al (2007) Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins. Clin Neuropharmacol 30:86-94
-
(2007)
Clin Neuropharmacol
, vol.30
, pp. 86-94
-
-
Wohlfarth, K.1
Muller, C.2
Sassin, I.3
-
14
-
-
0027984226
-
Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients
-
7964805 10.1136/jnnp.57.11.1321 1:STN:280:DyaK2M%2FlsVWjtw%3D%3D
-
Hesse S, Lücke D, Malezic M et al (1994) Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 57:1321-1324
-
(1994)
J Neurol Neurosurg Psychiatry
, vol.57
, pp. 1321-1324
-
-
Hesse, S.1
Lücke, D.2
Malezic, M.3
-
15
-
-
0030016259
-
Use of botulinum toxin in stroke patients with severe upper limb spasticity
-
8676154 10.1136/jnnp.61.1.30 1:STN:280:DyaK283ns1elsA%3D%3D
-
Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA (1996) Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 61:30-35
-
(1996)
J Neurol Neurosurg Psychiatry
, vol.61
, pp. 30-35
-
-
Bhakta, B.B.1
Cozens, J.A.2
Bamford, J.M.3
Chamberlain, M.A.4
-
16
-
-
0029951449
-
Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
-
8628472 10.1212/WNL.46.5.1306 1:STN:280:DyaK283ht1Gltw%3D%3D
-
Simpson DM, Alexander DN, O'Brien CF et al (1996) Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 46:1306-1310
-
(1996)
Neurology
, vol.46
, pp. 1306-1310
-
-
Simpson, D.M.1
Alexander, D.N.2
O'Brien, C.F.3
-
17
-
-
0033926243
-
Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial
-
10896696 10.1136/jnnp.69.2.217 1:STN:280:DC%2BD3cvgsFCmsA%3D%3D
-
Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM (2000) Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 69:217-221
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.69
, pp. 217-221
-
-
Bhakta, B.B.1
Cozens, J.A.2
Chamberlain, M.A.3
Bamford, J.M.4
-
18
-
-
0033800715
-
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke
-
11022071 10.1161/01.STR.31.10.2402 1:CAS:528:DC%2BD3cXnsVKqtrg%3D
-
Bakheit AM, Thilmann AF, Ward AB et al (2000) A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 31:2402-2406
-
(2000)
Stroke
, vol.31
, pp. 2402-2406
-
-
Bakheit, A.M.1
Thilmann, A.F.2
Ward, A.B.3
-
19
-
-
0034067174
-
Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study
-
10811692 10.1136/jnnp.68.6.707 1:STN:280:DC%2BD3c3ntF2lsg%3D%3D
-
Hyman N, Barnes M, Bhakta B et al (2000) Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry 68:707-712
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.68
, pp. 707-712
-
-
Hyman, N.1
Barnes, M.2
Bhakta, B.3
-
20
-
-
0037261997
-
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke
-
12686794 10.1159/000069495 1:CAS:528:DC%2BD3sXislKjsrk%3D
-
Pittock SJ, Moore AP, Hardiman O et al (2003) A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 15:289-300
-
(2003)
Cerebrovasc Dis
, vol.15
, pp. 289-300
-
-
Pittock, S.J.1
Moore, A.P.2
Hardiman, O.3
-
21
-
-
0141958550
-
Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients?
-
14530623 10.1159/000073058 1:CAS:528:DC%2BD3sXnvV2is7k%3D
-
Woldag H, Hummelsheim H (2003) Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients? Eur Neurol 50:165-171
-
(2003)
Eur Neurol
, vol.50
, pp. 165-171
-
-
Woldag, H.1
Hummelsheim, H.2
-
22
-
-
3242735082
-
Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke
-
15241751 10.1016/j.apmr.2003.10.015
-
Childers MK, Brashear A, Jozefczyk P et al (2004) Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. Arch Phys Med Rehabil 85:1063-1069
-
(2004)
Arch Phys Med Rehabil
, vol.85
, pp. 1063-1069
-
-
Childers, M.K.1
Brashear, A.2
Jozefczyk, P.3
-
23
-
-
0000270992
-
Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group
-
9826992 10.1002/(SICI)1097-4598(1997)6+<208: AID-MUS15>3.0.CO;2-1 1:STN:280:DyaK1M%2FksVahug%3D%3D
-
Brin MF (1997) Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Muscle Nerve Suppl 6:S208-S220
-
(1997)
Muscle Nerve Suppl
, vol.6
-
-
Brin, M.F.1
-
24
-
-
0036220846
-
Respective potencies of Botox and Dysport: A double blind, randomised, crossover study in cervical dystonia
-
11909903 1:STN:280:DC%2BD387nslejsQ%3D%3D
-
Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M (2002) Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72:459-462
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.72
, pp. 459-462
-
-
Ranoux, D.1
Gury, C.2
Fondarai, J.3
Mas, J.L.4
Zuber, M.5
-
25
-
-
6844239534
-
A, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia
-
9436720 10.1136/jnnp.64.1.6 1:STN:280:DyaK1c%2Fpslahsg%3D%3D
-
Odergren T, Hjaltason H, Kaakkola S et al (1998) A, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 64:6-12
-
(1998)
J Neurol Neurosurg Psychiatry
, vol.64
, pp. 6-12
-
-
Odergren, T.1
Hjaltason, H.2
Kaakkola, S.3
-
26
-
-
0030794264
-
Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm
-
9143885 10.1007/BF00941758
-
Nüssgens Z, Roggenkämper P (1997) Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 235:197-199
-
(1997)
Graefes Arch Clin Exp Ophthalmol
, vol.235
, pp. 197-199
-
-
Nüssgens, Z.1
Roggenkämper, P.2
-
27
-
-
0030725728
-
DYSPORT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A - Dysport and Botox - Assuming a ratio of 4:1
-
9399229 10.1002/mds.870120627 1:STN:280:DyaK1c%2FmtFKhtQ%3D%3D
-
Sampaio C, Ferreira JJ, Simões F et al (1997) DYSPORT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A - Dysport and Botox - assuming a ratio of 4:1. Mov Disord 12:1013-1018
-
(1997)
Mov Disord
, vol.12
, pp. 1013-1018
-
-
Sampaio, C.1
Ferreira, J.J.2
Simões, F.3
-
28
-
-
84863982462
-
® in the management of blepharospasm and hemifacial spasm: A novel paradigm for a never ending story
-
21710123 10.1007/s10072-011-0672-7
-
® in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story. Neurol Sci 33:261-267
-
(2012)
Neurol Sci
, vol.33
, pp. 261-267
-
-
Bentivoglio, A.R.1
Ialongo, T.2
Bove, F.3
De Nigris, F.4
Fasano, A.5
|